Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec): Bone marrow histopathology and correlation with genetic status

John L. Frater, Martin S. Tallman, Daina Variakojis, Brian J. Druker, Debra Resta, Mary Beth Riley, Mary Ann Hrisinko, Lo Ann C. Peterson

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint Dive into the research topics of 'Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec): Bone marrow histopathology and correlation with genetic status'. Together they form a unique fingerprint.

Medicine & Life Sciences